Figure 3.

Clinic SBP through the monotherapy and then double‐blind phases of the study. Patients later randomized to CLD add‐on are denoted by matching symbols during the monotherapy phase on the left of the figure. AZL‐M, azilsartan medoxomil; CLD, chlortalidone; SBP, systolic blood pressure